The successful candidate will break news on an industry that has benefited tremendously, both in terms of profit and influence, from developing vaccines and treatments critical to alleviating the COVID pandemic. At the same time, the industry is fending off efforts to curb the rising costs of prescription medicines and faces increasing pushback from national regulators over drug approvals.
This reporter would break news on how companies like Pfizer and Moderna will spend the billions of dollars earned off the pandemic, including a new push for acquisitions after a long hiatus. The candidate will report on how the pharma industry is exercising its enhanced leverage with governments, in Washington and abroad, seeking to sway major policy decisions on how drugs are approved and priced, from insulin to Alzheimer’s treatments.
The reporter would be deeply sourced among pharmaceutical and biotech executives, U.S. government health officials and industry investors. The preferred location for the role is New York.
About the Role
As our U.S. Pharmaceutical Industry Reporter, you will:
About You
To be our U.S. Pharmaceutical Industry Reporter, you will likely have:
(Internal candidates: Please note this position is incorrectly listed as being in the EIC job family).
Please note, the deadline for applications is Sunday 5th June 2022.
To apply, go here.
Former Business Insider executive editor Rebecca Harrington has been hired by Dynamo to be its…
Bloomberg Television has hired Brenda Kerubo as a desk producer in London. She will be covering Europe's…
In a meeting at CNBC headquarters Thursday afternoon, incoming boss Mark Lazarus presented a bullish…
Ritika Gupta, the BBC's North American business correspondent, was interviewed by Global Woman magazine about…
Rest of World has hired Kinling Lo as a China reporter. Lo was previously a…
Bloomberg News saw strong unique visitor growth to its website in October, passing Fox Business…